The Cancer Institute of New Jersey (Rutgers University) — New Brunswick, New Jersey

The Cancer Institute of New Jersey (Rutgers University) is a clinical research site located in New Brunswick, New Jersey, United States 08903.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

The Cancer Institute of New Jersey (Rutgers University) has participated in 2 clinical trials.

Therapeutic areas: Brain Metastases, Glioblastoma, Oligodendroglioma.

Sponsors: EpicentRx, Inc..

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Institute of New Jersey (Rutgers University)?

The Cancer Institute of New Jersey (Rutgers University) has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Institute of New Jersey (Rutgers University) conducted?

The Cancer Institute of New Jersey (Rutgers University) has 2 clinical trials on record. Their work covers Brain Metastases, Glioblastoma, Oligodendroglioma.

Is The Cancer Institute of New Jersey (Rutgers University) accredited by Crixeo Health?

The Cancer Institute of New Jersey (Rutgers University) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Cancer Institute of New Jersey (Rutgers University)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.